JPRN-UMIN000015482已完成4 期
Maintenance of remission with 6-week interval of tocilizumab in RA patients who have been in remission - Maintenance of remission by 6-week tocilizumab in RA patients
Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity0 个研究点目标入组 40 人开始时间: 2014年10月21日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
25 cases were enrolled
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have taken more than 5 mg/day of prednisolone
研究者
相似试验
进行中（未招募）
不适用
A 26-week extension to a 26-week treatment, multicenter, randomized, double-blind, placebo-controlled, adaptive, seamless, parallel-group study to assess safety, tolerability and efficacy of two doses of indacaterol (150 and 300 µg o.d.) in patients with chronic obstructive pulmonary disease.Chronic Obstructive Pulmonary Disease (COPD)MedDRA version: 9.1Level: LLTClassification code 10010952Term: COPDEUCTR2008-000663-42-DEovartis Pharma Services AG500
进行中（未招募）
不适用
A 26-week extension to a 26-week treatment, multicenter, randomized, double-blind, placebo-controlled, adaptive, seamless, parallel-group study to assess safety, tolerability and efficacy of two doses of indacaterol (150 and 300 μg o.d.) in patients with chronic obstructive pulmonary disease. - NDBPCOMedDRA version: 9.1Level: LLTClassification code 10009026Term: Chronic obstructive airways diseaseEUCTR2008-000663-42-ITOVARTIS FARMA1,300
进行中（未招募）
不适用
A 26-week extension to a 26-week treatment, multicenter, randomized, double-blind, placebo-controlled, adaptive, seamless, parallel-group study to assess safety, tolerability and efficacy of two doses of indacaterol (150 and 300 µg o.d.) in patients with chronic obstructive pulmonary disease.EUCTR2008-000663-42-SEovartis Pharma Services AG417
已完成
3 期
Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)CTRI/2009/091/000216ovartis Healthcare Pvt Ltd418
已完成
4 期
Evaluation of the longterm Clinical Performance of two Composites for the Restoration of Class II cavitiesK02Dental cariesDRKS000135643M Deutschland GmbH 3M Oral Care30